This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
R. Agranoff , & M McGuire . (2001). Big questions in public network management research. Journal of Public Administration Research and Theory, 11(3), 295–326.
K. Anderson , D. Stowasser , C. Freeman , & I Scott . (2014). Prescriber barriers and enablers to minimising potentially inappropriate medications in adults: a systematic review and thematic synthesis. BMJ Open, 4(12). e006544.
, M. Bertrand
, J.-F. Dartigues
, A. Fourrier
, B. Tavernier
, K. Ritchie
, & A Alpérovitch
). Inappropriate medication use and risk of falls – A prospective study in a large community-dwelling elderly cohort
. BMC Geriatrics
). doi: 10.1186/1471-2318-9-30
A. Bergkvist , P. Midlöv , P. Höglund , L. Larsson , & T Eriksson . (2009). A multi-intervention approach on drug therapy can lead to a more appropriate drug use in the elderly. LIMM-Landskrona Integrated Medicines Management. Journal of Evaluation in Clinical Practice, 15(4), 660–667.
K. D. Bess , P. W. Speer , & D. D Perkins . (2012). Ecological contexts in the development of coalitions for youth violence prevention: An organizational network analysis. Health Education & Behavior, 39(5), 526–537.
A. Best , T. Greenhalgh , S. Lewis , J. E. Saul , S. Carroll , & J Bitz . (2012). Large-system transformation in health care: A realist review. Milbank Quarterly, 90(3), 421–456.
A. S. Bierman , M. J. V. Pugh , I. Dhalla , M. Amuan , B. G. Fincke , A. Rosen , & D. R Berlowitz . (2007). Sex differences in inappropriate prescribing among elderly veterans. The American Journal of Geriatric Pharmacotherapy, 5(2), 147–161.
M. Boulin , V. Diaby , & C Tannenbaum . (2016). Preventing unnecessary costs of drug-induced hypoglycemia in older adults with type 2 diabetes in the United States and Canada. PLoS One, 11(9). e0162951.
D. S. Budnitz , M. C. Lovegrove , N. Shehab , & C. L Richards . (2011). Emergency hospitalizations for adverse drug events in older Americans. New England Journal of Medicine, 365(21), 2002–2012.
S. R. Chaudoir
, A. G. Dugan
, & C. H Barr
). Measuring factors affecting implementation of health innovations: A systematic review of structural, organizational, provider, patient, and innovation level measures
. Implementation Science
). doi: 10.1186/1748-5908-8-22
Y.-C. Chen , & D. H Kreling . (2014). The effect of the Medicare part D benzodiazepine exclusion on the utilization patterns of benzodiazepines and substitute medications. Research in Social and Administrative Pharmacy, 10(2), 438–447.
A. Y. Cheng , & D. C Lau . (2013). The Canadian Diabetes Association 2013 clinical practice guidelines – Raising the bar and setting higher standards!
Canadian Journal of Diabetes, 37(3), 137–138.
C. H Colla . (2014). Swimming against the current – What might work to reduce low-value care?
New England Journal of Medicine, 371(14), 1280–1283.
, B. Farrell
, N. Ward
, L. McCarthy
, H. Irving
, & L Raman-Wilms
). Developmental evaluation as a strategy to enhance the uptake and use of deprescribing guidelines: Protocol for a multiple case study
. Implementation Science
). doi: 10.1186/s13012-015-0279-0
P. E Cryer . (2008). The barrier of hypoglycemia in diabetes. Diabetes, 57(12), 3169–3176.
L. J. Damschroder
, D. C. Aron
, R. E. Keith
, S. R. Kirsh
, J. A. Alexander
, & J. C Lowery
). Fostering implementation of health services research findings into practice: A consolidated framework for advancing implementation science
. Implementation Science
. doi: 10.1186/1748-5908-4-50
B. Farrell , C. Tsang , L. Raman-Wilms , H. Irving , J. Conklin , & K Pottie . (2015). What are priorities for deprescribing for elderly patients? Capturing the voice of practitioners: A modified delphi process. PLoS One, 10(4). e0122246
, K. L. Lanctôt
, N. Herrmann
, B. A. Sproule
, & U. E Busto
). Sedative hypnotics in older people with insomnia: Meta-analysis of risks and benefits
. British Medical Journal
D. Gnjidic , D. G. Le Couteur , L. Kouladjian , & S. N Hilmer . (2012). Deprescribing trials: Methods to reduce polypharmacy and the impact on prescribing and clinical outcomes. Clinics in Geriatric Medicine, 28(2), 237–253.
W. Gomm , K. von Holt , F. Thomé , K. Broich , W. Maier , A. Fink , … & B Haenisch . (2016). Association of proton pump inhibitors with risk of dementia: A pharmacoepidemiological claims data analysis. JAMA Neurology, 73(4), 410–416.
C. M. Hohl
, B. Nosyk
, L. Kuramoto
, P. J. Zed
, J. R. Brubacher
, R. B. Abu-Laban
, … & B Sobolev
). Outcomes of emergency department patients presenting with adverse drug events
. Annals of Emergency Medicine
. doi: 10.1186/1472-6963-13-473
H. M. Holmes , L. C. Min , M. Yee , R. Varadhan , J. Basran , W. Dale , & C. M Boyd . (2013). Rationalizing prescribing for older patients with multimorbidity: Considering time to benefit. Drugs & Aging, 30(9), 655–666.
J. G. Howlett , M. Chan , J. A. Ezekowitz , K. Harkness , G. A. Heckman , S. Kouz , … & H Abrams . (2016). The Canadian cardiovascular society heart failure companion: Bridging guidelines to your practice. Canadian Journal of Cardiology, 32(3), 296–310.
S. Iyer , V. Naganathan , A. J. McLachlan , & D. G Le Conteur . (2008). Medication withdrawal trials in people aged 65 years and older. Drugs & Aging, 25(12), 1021–1031.
B. Jafari , & M. E Britton . (2015). Hypoglycaemia in elderly patients with type 2 diabetes mellitus: A review of risk factors, consequences and prevention. Journal of Pharmacy Practice and Research, 45(4), 459–469.
S. Kaur , G. Mitchell , L. Vitetta , & M. S Roberts . (2009). Interventions that can reduce inappropriate prescribing in the elderly. Drugs & Aging, 26(12), 1013–1028.
P. Kenis , & K. G Provan . (2009). An exogenous theory of public network performance. Public Administration, 87, 440–456.
P. O. Lang
, N. Vogt-Ferrier
, Y. Hasso
, L. Le Saint
, M. Dramé
, D. Zekry
, … & M Prudent
). Interdisciplinary geriatric and psychiatric care reduces potentially inappropriate prescribing in the hospital: Interventional study in 150 acutely ill elderly patients with mental and somatic comorbid conditions
. Journal of the American Medical Directors Association
Z. A. Marcum , M. E. Amuan , J. T. Hanlon , S. L. Aspinall , S. M. Handler , C. M. Ruby , & M. J. V Pugh . (2012). Prevalence of unplanned hospitalizations caused by adverse drug reactions in older veterans. Journal of the American Geriatrics Society, 60(1), 34–41.
S. Michie , M. M. van Stralen , & R West . (2011). The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implementation Science, 6(1), 42.
S. G. Morgan
, J. Hunt
, J. Rioux
, J. Proulx
, D. Weymann
, & C Tannenbaum
). Frequency and cost of potentially inappropriate prescribing for older adults: A cross-sectional study
. CMAJ Open
). doi: 10.9778/cmajo.20150131
A. Mudge , K. Radnedge , K. Kasper , R. Mullins , J. Adsett , S. Rofail , … & M Barras . (2016). Effects of a pilot multidisciplinary clinic for frequent attending elderly patients on deprescribing. Australian Health Review, 40(1), 86–91.
J. Muscedere , M. K. Andrew , S. M. Bagshaw , C. Estabrooks , D. Hogan , J. Holroyd-Leduc , … & M McNally . (2016). Screening for frailty in Canada’s health care system: A time for action. Canadian Journal on Aging/La Revue canadienne du vieillissement, 35(3), 1–17.
, C. Ståhl
, K. Roback
, & P Cairney
). Never the twain shall meet? – A comparison of implementation science and policy implementation research
. Implementation Science
). doi: 10.1186/178-5908-8-63
D. J. Niven
, K. J. Mrklas
, J. K. Holodinsky
, S. E. Straus
, B. R. Hemmelgarn
, L. P. Jeffs
, & H. T Stelfox
). Towards understanding the de-adoption of low-value clinical practices: A scoping review
. BMC Medicine
). doi: 10.1186/s12916-015-0488-z
, D. O’Sullivan
, S. Byrne
, M. N. O’Connor
, C. Ryan
, & P Gallagher
). STOPP/START criteria for potentially inappropriate prescribing in older people: Version 2
. Age and Ageing
. doi: 10.1093/ageing/afu145
D. Opondo , S. Eslami , S. Visscher , S. E. De Rooij , R. Verheij , J. C. Korevaar , & A Abu-Hanna . (2012). Inappropriateness of medication prescriptions to elderly patients in the primary care setting: A systematic review. PLoS One, 7(8). e43617.
J. Proulx , & J Hunt . (2014). Drug use among seniors on public drug programs in Canada, 2012. Healthcare Quarterly (Toronto, Ont.), 18(1), 11–13.
K. G. Provan , & P Kenis . (2008). Modes of network governance: Structure, management, and effectiveness. Journal of Public Administration Research and Theory, 18(2), 229–252.
E. Reeve , J. To , I. Hendrix , S. Shakib , M. S. Roberts , & M. D Wiese . (2013). Patient barriers to and enablers of deprescribing: A systematic review. Drugs & Aging, 30(10), 793–807.
E. Reeve , & M. D Wiese . (2014). Benefits of deprescribing on patients’ adherence to medications. International Journal of Clinical Pharmacy, 36(1), 26–29.
P. A. Rochon , A. Gruneir , S. S. Gill , W. Wu , H. D. Fischer , S. E. Bronskill , … & C. M Bell . (2013). Older men with dementia are at greater risk than women of serious events after initiating antipsychotic therapy. Journal of the American Geriatrics Society, 61(1), 55–61.
P. A. Rochon , & J. H Gurwitz . (1997). Optimising drug treatment for elderly people: The prescribing cascade. BMJ: British Medical Journal, 315(7115), 1096–1099.
A. L. Schaffer , N. A. Buckley , R. Cairns , & S.A Pearson . (2016). Interrupted time series analysis of the effect of rescheduling alprazolam in Australia: Taking control of prescription drug use. JAMA Internal Medicine, 176(8), 1223–1225.
A. J. Schoenfeld , & D Grady . (2016). Adverse effects associated with proton pump inhibitors. JAMA Internal Medicine, 176(2), 172–174.
I. A. Scott , S. N. Hilmer , E. Reeve , K. Potter , D. Le Couteur , D. Rigby , … & A Page . (2015). Reducing inappropriate polypharmacy: The process of deprescribing. JAMA Internal Medicine, 175(5), 827–834.
L. C. Sera , & M. L McPherson . (2012). Pharmacokinetics and pharmacodynamic changes associated with aging and implications for drug therapy. Clinics in Geriatric Medicine, 28(2), 273–286.
A. Spinewine , K. E. Schmader , N. Barber , C. Hughes , K. L. Lapane , C. Swine , & J. T Hanlon . (2007). Appropriate prescribing in elderly people: How well can it be measured and optimised?
The Lancet, 370(9582), 173–184.
C. Tannenbaum , V. Diaby , D. Singh , S. Perreault , M. Luc , & H.-M Vasiliadis . (2015). Sedative-hypnotic medicines and falls in community-dwelling older adults: A cost-effectiveness (decision-tree) analysis from a US Medicare perspective. Drugs & Aging, 32(4), 305–314.
C. Tannenbaum , P. Martin , R. Tamblyn , A. Benedetti , & S Ahmed . (2014). Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial. JAMA Internal Medicine, 174(6), 890–898.
W. Thompson , & B Farrell . (2013). Deprescribing: What is it and what does the evidence tell us?
The Canadian Journal of Hospital Pharmacy, 66(3), 201–202.
A. Todd , & H. M Holmes . (2015). Recommendations to support deprescribing medications late in life. International Journal of Clinical Pharmacy, 37(5), 678–681.
D. Trivedi , C. Goodman , H. Gage , N. Baron , F. Scheibl , S. Iliffe , … & V Drennan . (2013). The effectiveness of inter-professional working for older people living in the community: A systematic review. Health and Social Care in the Community, 21(2), 113–128.
J. P. Turner , S. Edwards , M. Stanners , S. Shakib , & J. S Bell . (2016). What factors are important for deprescribing in Australian long-term care facilities? Perspectives of residents and health professionals. BMJ Open, 6(3). e009781.
M. C Woodward . (2003). Deprescribing: Achieving better health outcomes for older people through reducing medications. Journal of Pharmacy Practice and Research, 33(4), 323–328.
C. Wu , C. M. Bell , & W. P Wodchis . (2012). Incidence and economic burden of adverse drug reactions among elderly patients in Ontario emergency departments. Drug Safety, 35(9), 769–781.
P. J. Zed , R. B. Abu-Laban , R. M. Balen , P. S. Loewen , C. M. Hohl , J. R. Brubacher , … & K Lacaria . (2008). Incidence, severity and preventability of medication-related visits to the emergency department: A prospective study. Canadian Medical Association Journal, 178(12), 1563–1569.